Answers are grounded in this paper and cite their sources.
Amyloid beta-peptide (A beta) aggregates are one of the key neuropathological characteristics of Alzheimer's disease. A beta belongs to a group of proteins that aggregate and form beta-sheets, and some of these proteins bind cholesterol and other lipids. The purpose of the experiments reported here was to determine if cholesterol, fatty acids, and phosphatidylcholine (PC) would bind to A beta(1-40) and if such binding would be dependent on aggregation of A beta(1-40). Lipid binding was determined using fluorescent-labeled lipids. Incubation of A beta(1-40) for 0, 1, 3, 6, 21, and 24 h resulted in aggregation of the peptide with formation of dimers, trimers (1-24 h), and polymers (6-24 h) as determined by sodium dodecyl sulfate-gel electrophoresis. No change in the fluorescence of the lipids was observed when lipids were added to A beta(1-40) that had been incubated for 0, 1, or 3 h. However, the fluorescence intensities of cholesterol, saturated fatty acids, and PC were significantly increased (p < 0.0001) when added to A beta(1-40) that had been incubated for 6, 21, and 24 h in which A beta(1-40) polymers were detected. The binding affinity of cholesterol to A beta(1-40) polymers (K(D) of 3.24 +/- 0.315 x 10(-9) M) was markedly higher as compared with the other lipids (stearic acid, 9.42 +/- 0.41 x 10(-8) M; PC, 7.07 +/- 0.12 x 10(-7) M). The results of this study indicate that A beta(1-40) polymers bind lipids and have a higher affinity for cholesterol than PC or saturated fatty acids. Aggregated A beta(1-40) may affect lipid transport between cells or remove specific lipids from membranes, and such effects could contribute to neuronal dysfunction.
No takes yet. Share an insight, caveat, or question.
Avdulov et al. (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: